CD44 and cancer: Quite unexpectedly, we also identified Cluster 4 to be enriched for small population of both EpCAMhigh and EpCAMlow cells with CD90/CD44/Vimentin/Ki‐67high molecular profile, resembling proliferative cancer stem‐like (CSC) subpopulation (Fig. 2F).